Research priorities in pharmacokinetics
- PMID: 22360418
- PMCID: PMC3391520
- DOI: 10.1111/j.1365-2125.2012.04238.x
Research priorities in pharmacokinetics
Abstract
An opinion is expressed on the past, present and future roles of pharmacokinetic-pharmacodynamic research in the context of UK clinical pharmacology. On the basis of its current constitution, it seems unlikely that this area of research will be driven from within academic clinical pharmacology in the UK. Therefore, in order to bring its expertise and experience to bear effectively on the evolving emphasis on translational medicine and modelling and simulation, this community would need to reach out beyond its current preoccupations to increase interactions with the next generation of pharmacokineticists and pharmacometricians.
© 2012 The Author. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
Similar articles
-
Pediatric pharmacology: current efforts and future goals to improve clinical practice.Expert Opin Drug Metab Toxicol. 2015;11(11):1679-82. doi: 10.1517/17425255.2015.1065815. Epub 2015 Jul 13. Expert Opin Drug Metab Toxicol. 2015. PMID: 26166262
-
Expanding clinical applications of population pharmacodynamic modelling.Br J Clin Pharmacol. 1998 Oct;46(4):321-33. doi: 10.1046/j.1365-2125.1998.00792.x. Br J Clin Pharmacol. 1998. PMID: 9803979 Free PMC article. Review.
-
The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics.Drug Discov Today. 2007 Dec;12(23-24):1018-24. doi: 10.1016/j.drudis.2007.10.002. Epub 2007 Nov 19. Drug Discov Today. 2007. PMID: 18061880 Review.
-
Qualitative pharmacokinetic modeling of drugs.AMIA Annu Symp Proc. 2005;2005:71-5. AMIA Annu Symp Proc. 2005. PMID: 16779004 Free PMC article.
-
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development.Eur J Pharm Sci. 2017 Nov 15;109S:S53-S58. doi: 10.1016/j.ejps.2017.05.042. Epub 2017 May 20. Eur J Pharm Sci. 2017. PMID: 28535992 Review.
Cited by
-
Challenges and opportunities in the advancement of nanomedicines.J Control Release. 2012 Dec 10;164(2):236-46. doi: 10.1016/j.jconrel.2012.10.007. Epub 2012 Oct 12. J Control Release. 2012. PMID: 23064314 Free PMC article.
References
-
- Smith SE, Rawlins MD. Variability in Human Drug Response. London: Butterworths; 1973.
-
- Dollery CT. Pharmacokinetics – master or servant? Eur J Clin Pharmacol. 1973;6:1–2. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous